Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

Go on, give it a shot. Ozempic and other game-changing weight loss drugs are popular for a reason — but, nutrition experts ...

HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...

Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...